Regulations regarding Fees Payable in terms of the provisions of the Medicines and Related Substances Act, 1965 (Act No. 101 of 1965), 2025

Purchase cart Previous page Return to chapter overview Next page

 

Notice No. 5856 of 2025

1. Definitions

2. Fees payable to the Chief Executive Officer or Director-General

3. Category A medicines (Human Medicines)

4. Category C medicines (Veterinary Medicines)

5. Category D medicines (Human medicines)

6. Category D medicines (Veterinary medicines)

7. Fees for clinical trials (Human and Veterinary)

8. Fees for Licences (including Medical Devices/IVD's and Complementary Medicines)

9. Fees for inspections to assess quality, safety and efficacy of medicines and scheduled substances

10. Fees for permits and certificates

11. Amendment of information in the register

12. Transfer of certificates of registration

13. Appeal against the decision of the authority

14. Repeal of laws

15. Short title